3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
16
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Squamous Cell Carcinoma of Head and Neck
7
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Nasopharyngeal Carcinoma
4
Ovarian Neoplasms
3
Uterine Cervical Dysplasia
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Malnutrition
2
Lung Neoplasms
2
Biliary Tract Neoplasms
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Salivary Gland Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ototoxicity
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Neoplastic Cells, Circulating
1
Neoplasms, Second Primary
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Kidney Diseases
1
Gallbladder Neoplasms
1
Interventions
Hepatectomy
10
Blood Specimen Collection
9
Sorafenib
7
Polymerase Chain Reaction
4
Biopsy
4
regorafenib
3
Mass Spectrometry
3
Liver Transplantation
3
Immunohistochemistry
3
Chemoembolization, Therapeutic
3
Walking Speed
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Magnetic Resonance Imaging
2
Gene Expression Profiling
2
Bevacizumab
2
trastuzumab deruxtecan
1
taxane
1
spartalizumab
1
sintilimab
1
lenvatinib
1
gadolinium ethoxybenzyl DTPA
1
donafenib
1
carmofur
1
camrelizumab
1
cabozantinib
1
atezolizumab
1
apatinib
1
anlotinib
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Liver Neoplasms
×
Cisplatin
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled